Get the Stockscreener App
42.94
2.39%
1.0225
Grail Inc stock is traded at $42.94, with a volume of 358.50K.
It is up +2.39% in the last 24 hours and up +0.07% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$41.92
Open:
$41
24h Volume:
358.50K
Relative Volume:
0.27
Market Cap:
$1.42B
Revenue:
$117.67M
Net Income/Loss:
$-1.88B
P/E Ratio:
-0.7094
EPS:
-60.5369
Net Cash Flow:
$-621.36M
1W Performance:
+11.89%
1M Performance:
+0.07%
6M Performance:
+93.68%
1Y Performance:
+0.00%
1-Day Range:
$40.30
$43.17
1-Week Range:
$35.50
$44.37
52-Week Range:
$12.33
$63.99
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
42.92 | 1.42B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
410.80 | 150.38B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
203.98 | 137.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
525.17 | 42.00B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
118.55 | 32.37B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.67 | 25.50B | 15.50B | 1.33B | 2.16B | 7.34 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
Grail Inc Stock (GRAL) Latest News
California State Teachers Retirement System Takes $464,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
67,288 Shares in Grail, Inc. (NASDAQ:GRAL) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
NINGI short Grail, says ‘approval and commercialization all but impossible’ - TipRanks
GRAIL stock tumbles on short-seller report By Investing.com - Investing.com Nigeria
GRAIL stock tumbles on short-seller report - Investing.com
Ningi Research Says Short Grail - marketscreener.com
3 Medical Technology Stocks Outperforming in 2025 - inkl
GRALGRAIL Reports First Quarter 2025 Financial Results - mx.advfn.com
Wellington Management Group LLP Takes Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Two Sigma Advisers LP Makes New $345,000 Investment in Grail, Inc. (NASDAQ:GRAL) - Defense World
For FMCG Inc., the holy grail of volume growth is in sight | Company Business News - Mint
Nuveen Asset Management LLC Takes $837,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
Transcript : GRAIL, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 11 - marketscreener.com
BNP Paribas Financial Markets Invests $50,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
Ameriprise Financial Inc. Takes $681,000 Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL, Inc. (GRAL) Stock Analysis: Evaluating the 19.10% Revenue Growth Against Market Challenges - DirectorsTalk Interviews
96,630 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Two Sigma Investments LP - Defense World
GRAIL announces inducement grants - Medical Buyer
Grail Inc. stockholders elect director, ratify auditor By Investing.com - Investing.com Nigeria
Grail Inc. stockholders elect director, ratify auditor - Investing.com
GRAIL Inc Holds Annual Stockholders Meeting - TipRanks
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire
Grail (GRAL) and Its Competitors Head-To-Head Analysis - Defense World
Rêve Health to Offer GRAIL’s Galleri® Multi-Cancer Early Detection Test - Fitt Insider
Millennium Management LLC Takes $5.28 Million Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
(GRAL) Technical Data - news.stocktradersdaily.com
Man Group plc Buys New Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
56,062 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Deutsche Bank AG - Defense World
145,949 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Northern Trust Corp - Defense World
Janus Henderson Group PLC Invests $223,000 in Grail, Inc. (NASDAQ:GRAL) - Defense World
595,962 Shares in Grail, Inc. (NASDAQ:GRAL) Bought by Bank of America Corp DE - Defense World
Early Cancer Detection Pioneer GRAIL Reveals Latest Advances at Major Healthcare Conference - Stock Titan
GRAIL to Present at Jefferies Global Healthcare Conference 2025 - PR Newswire
Liquid Biopsy Market Is Booming So Rapidly | GRAIL, Freenome, Natera - openPR.com
How to Take Advantage of moves in (GRAL) - news.stocktradersdaily.com
Dimensional Fund Advisors LP Buys New Position in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL falls 16% after Q1 topline miss - MSN
GRAIL First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Biotech startup Grail (GRAL) gets grilled on its cash burn - Investorsobserver
Gravity study shows why the moon's two sides look so different - marketscreener.com
Health Care Sector Slips While Incannex Rockets Ahead - Finimize
Sector Update: Health Care - marketscreener.com
GRAIL and athenahealth partner to simplify ordering of cancer detection test - MSN
GRAIL outlines 2025 commercial growth plans and targets up to 30% US Galleri revenue increase - MSN
Alcon, American Eagle, GRAIL And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Grail partners with athenahealth for MCED test ordering - Yahoo Finance
Grail price target raised to $43 from $32 at Canaccord - TipRanks
GRAIL stock price target raised to $43 by Canaccord Genuity - Investing.com Nigeria
Price T Rowe Associates Inc. MD Acquires New Shares in Grail, Inc. (NASDAQ:GRAL) - Defense World
GRAIL Inc Reports Q1 2025 Earnings: Revenue Hits $31.8 Million A - GuruFocus
Grail Q1 2025 Earnings Call Transcript - MarketBeat
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Grail Inc Stock (GRAL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ofman Joshua J. | President |
May 02 '25 |
Sale |
33.93 |
48,213 |
1,635,867 |
511,460 |
| Freidin Aaron | Chief Financial Officer |
May 02 '25 |
Sale |
33.93 |
41,150 |
1,396,220 |
294,020 |
| RAGUSA ROBERT P | Chief Executive Officer |
May 02 '25 |
Sale |
33.93 |
94,035 |
3,190,608 |
734,627 |
1.45%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):